Skip to main content
Caplight Logo









Zolvia

Zolvia

Private
DublinHealthcare & Life Scienceshttps://zolvia.ie

Last Round

Pre Seed

Jul 1, 2024

Total Funding Raised

$220,000

Company Overview

Zolvia operates in Healthcare & Life Sciences and is based in Dublin. Its latest recorded funding round was a Pre Seed round in July 2024.

Zolvia is a food and beverage technology company that develops formulation technologies to improve the solubility, stability, and bioavailability of active ingredients in functional foods and beverages.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Advanced Materials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Zolvia Comparables

Compare Zolvia with similar companies based on industry and business-model similarity.

Zolvia comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Plasma Nutrition
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Zolvia Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedJul 1, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Ferdia Doherty

Co-Founder & Chief Operating Officer

Founding Team

Nicholas Deeney

Co-Founder & CEO

Founding Team

For institutional investors. Book with your work email.

Zolvia Investors

Notable investors and investment history

Zolvia investors
InvestorRounds
Enterprise IrelandPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 12, 2025

    Grew 100% QoQ from 3 to 6 employees.

  • Jul 1, 2024

    $220K round with Enterprise Ireland

Book a demo to see all signals

For institutional investors. Book with your work email.

Zolvia Filings

Explore SEC and related filing metadata, where available.

Zolvia filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Zolvia's valuation, stock price, and market status.

Is Zolvia a public or private company?

Zolvia is a private company.

What is the current stock price of Zolvia?

Zolvia is a private company, so its shares have no public market price. Caplight tracks Zolvia's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Zolvia worth (valuation)?

Valuation information for Zolvia is not publicly available.

Can I buy Zolvia stock?

Zolvia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Zolvia's last funding round?

Zolvia's most recent funding round was Pre Seed on July 1, 2024.

Who are the main investors in Zolvia?

Key investors in Zolvia include Enterprise Ireland.

Will Zolvia IPO soon?

No public IPO plans have been announced for Zolvia.

How can I track Zolvia secondary market activity?

Caplight tracks bids, offers, and trades in Zolvia's shares on secondary markets.

Firmographic Details

HeadquartersDublin
Employee Range5
Year Founded2023
Last FundingJul 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?